Navigation Links
Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
Date:8/12/2008

Owing to Well-Established and Effective Insulin-Based Therapies, Market Growth Will be Modest Through 2017, According to a New Report from Decision

Resources

WALTHAM, Mass., Aug. 12 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the most significant driver of growth in the type 1 diabetes market will be the shift in the standard of care away from regular human insulins and neutral protamine Hagedorn (NPH) insulin to more-expensive rapid-acting insulin analogues and long-acting insulin analogues. Short-acting insulin analogues provide a more rapid onset of action than regular human insulin and long-acting insulin analogues require fewer injections than NPH insulin.

The new Pharmacor report entitled Type 1 Diabetes finds that market growth will be driven by rapid-acting insulin analogues that include Novo Nordisk's Novorapid/Novolog and Eli Lilly's Humalog as well as long-acting insulin analogues that include Sanofi-Aventis's Lantus and Novo Nordisk's Levemir. Since the type 1 diabetes market is saturated with effective and well-established insulin-based therapies that have been in use for decades, the report forecasts only modest 1.2 percent annual market growth through 2017.

According to the report, novel devices designed to allow needle-free administration of insulin could revolutionize treatment of type 1 diabetes, but their uptake will be hampered by physicians' negative experience with Pfizer/Nektar's inhaled insulin, Exubera, which fared poorly in the market owing to safety concerns and its premium price. Among the insulin-based therapies currently in the pipeline for type 1 diabetes, oral and transdermal insulins hold the greatest promise but their use will be constrained by dosing variability issues that are likely to dissuade physicians from prescribing them.

The report also finds that novel immu
'/>"/>

SOURCE Decision Resources, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Nature Publication Reports on Key Role of Bile Acids in Glucose Metabolism and Insulin Signaling
2. New Survey Explores the Impact of Insulin Injections and Communications Between Patients and Healthcare Providers
3. Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial of its Oral Insulin Capsule
4. Treatment Corrects Severe Insulin Imbalance in Animal Studies
5. Oramed Pharmaceuticals to Hold Conference Call on August 6 to Present Results of Phase 2A Oral Insulin Capsule Clinical Trials
6. Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes
7. Emisphere Announces Data From Independent Clinical Study of Effects of Oral GLP-1 on Glucose and Insulin Concentrations
8. Novel Testosterone Gel Significantly Improves Insulin Sensitivity and Sexual Function in Hypogonadal Men With Type 2 Diabetes and Metabolic Syndrome
9. Use of Mealtime SYMLIN(R) Compared to Rapid-Acting Insulin for Diabetes Therapy Intensification in Patients With Type 2 Diabetes Using Basal Insulin
10. Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability
11. Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... , May 22, 2013  For the 3% of the ... is often embarrassing, uncomfortable, anxiety-inducing and disabling.  While more ... treated for their symptoms, hyperhidrosis is a serious medical ... available called Precision TX™. Dr. ... & Laser Center in New York ...
(Date:5/22/2013)... May 22, 2013  Modern Medical announced today ... Launched in November 2012 in a test phase, ... to stop the rising opioid abuse in the ... program designed to protect employees, physicians and employers ... necessary balance to provide pain relief for the ...
(Date:5/22/2013)... 2013 STEPh, Inc., a full service medical ... their web site ( http://www.stephreports.com ) dedicated ... About STEPh Reports STEPh Reports are comprehensive ... Each STEPh Report assesses the competitive landscape by individual ... company, and specific key issues.  STEPh Reports are written ...
Breaking Medicine Technology:Is There Finally A Way To Stop Severe Excessive Sweating? 2Modern Medical Introduces Opioid Abuse Solution to the Workers' Compensation Industry 2Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site 2
... Oct. 20 Young Innovations, Inc. (Nasdaq: YDNT ) ... quarter and the nine-months ended September 30, 2010. ... increase of 6.5% over the $24.8 million reported for the third ... 7.6% to $6.1 million from $5.7 million in the prior year ...
... INDIANAPOLIS, Oct. 20 MacroGenics, Inc. and Eli Lilly ... that the Protege Data Monitoring Committee (DMC), composed of ... has completed a planned analysis of one-year safety and ... of teplizumab, an investigational biologic under development for the ...
Cached Medicine Technology:Young Innovations, Inc. Announces Record Sales and EPS for the Quarter and Nine-Months Ended September 30, 2010 and Declares Quarterly Dividend 2Young Innovations, Inc. Announces Record Sales and EPS for the Quarter and Nine-Months Ended September 30, 2010 and Declares Quarterly Dividend 3Young Innovations, Inc. Announces Record Sales and EPS for the Quarter and Nine-Months Ended September 30, 2010 and Declares Quarterly Dividend 4Young Innovations, Inc. Announces Record Sales and EPS for the Quarter and Nine-Months Ended September 30, 2010 and Declares Quarterly Dividend 5MacroGenics and Lilly Announce Pivotal Clinical Trial of Teplizumab Did Not Meet Primary Efficacy Endpoint 2MacroGenics and Lilly Announce Pivotal Clinical Trial of Teplizumab Did Not Meet Primary Efficacy Endpoint 3
(Date:5/22/2013)... of internal medicine residents at Massachusetts General Hospital (MGH) ... found that more than half rated the training they ... as fair or poor. Significant numbers felt unprepared to ... of practicing physicians. In response to the findings, recently ... the MGH has increased residents, training in addiction medicine. ...
(Date:5/22/2013)... father,s depression have on his young son or daughter? When ... marriage, their children benefit, said a University of Illinois study. ... need to be able to attend to the child,s emotional ... and notice whether he is getting frustrated or needs help. ... a U of I professor of human development. , But ...
(Date:5/22/2013)... IL A new study suggests that disturbed ... of depression and greater uncertainly about future success. ... and teachers appears to have a protective effect. ... significantly associated with depressed mood and greater uncertainty ... from parents and from teachers were associated with ...
(Date:5/22/2013)... plants" that make energy to keep cells alive is ... the drug-resistant forms of cancer source of a ... of a new study published in the journal ... colleagues explain that doxorubicin and other common forms of ... of cancer cells. Cancer cells divide and multiply faster ...
(Date:5/22/2013)... The newest member of TeethWhiteningforFree.com is Dr. ... Alabama graduate, Dr. Sanderson provides professional dental care to ... he extends complimentary teeth whitening to his patients who ... up. Only a dental professional can decide if the ... , Teeth whitening is an easy way ...
Breaking Medicine News(10 mins):Health News:Survey points out deficiencies in addictions training for medical residents 2Health News:Survey points out deficiencies in addictions training for medical residents 3Health News:Survey points out deficiencies in addictions training for medical residents 4Health News:Good marriage can buffer effects of dad's depression on young children 2Health News:Parent and teacher support protects teens from sleep problems and depression 2Health News:Dr. James Sanderson, Jr. Of SanDentistry in Hoover, Alabama Joins the TeethWhiteningforFree.com Family 2
... A Closer Look at The Value of,MRIs ... of,America,s (MSAA) website, http://www.msassociation.org . This three ... offering a first-hand,account on the experience of undergoing ... well as the importance of MRIs to monitor ...
... N.C., June 5 Benchmarking is not a luxury;,it ... climates. This research,excerpt presents a survey analysis of 30 ... how companies are using benchmarking in a,difficult economy., ... companies are,choosing to benchmark, the goals of benchmarking studies, ...
... The Massachusetts School of,Professional Psychology, WEST ROXBURY, ... state about the ,invisible wounds of war, - ... depression and post traumatic,stress disorder (PTSD) - which ... and suicide. We need to begin focusing on ...
... information, giveaways, entertainment and ... ... with professional fitness and figure competitors Allison,Frahn and Tina Durkin, will represent ... Cobb Galleria Centre in Atlanta., Chad, part of the World Natural ...
... Cline Davis & Mann (CDM), a ... of its,newest division, Platform Advisors(TM). Platform Advisors, ... and scientific consulting,services for pharmaceutical, biotechnology, and ... firms, Platform Advisors combines the,expertise of seasoned ...
... barriers cited, particularly in construction jobs, CDC reports ... workers face a greater risk of dying from ... in the construction industry, U.S. health officials said ... workers died from work-related injuries. This represents approximately ...
Cached Medicine News:Health News:Photos: The Multiple Sclerosis Association of America Produces a Web Video on the Importance of MRIs 2Health News:Demonstrating the Value of Benchmarking in an Uncertain Economy 2Health News:Growing Public Health Crisis of Domestic Violence and Suicides by Returning Veterans 2Health News:Rite Aid Health and Beauty Expo to Showcase GNC Athletes 2Health News:Cline Davis & Mann Launches Platform Advisors(TM), a New Division to Provide Integrated Strategic and Scientific Consulting Services for the Pharmaceutical, Biotechnology, and Medical Device Industry 2Health News:Hispanic Workers Dying at Higher Rates Than Others 2Health News:Hispanic Workers Dying at Higher Rates Than Others 3
... SpecTRACK Software is an Informatics software product ... of specimens for the laboratory. With SpecTRACK ... location of any specimen from all laboratories ... in the refrigerator or cold room. Automate ...
PediaVision LLC is a life sciences company dedicated to solving the critical problem of undiagnosed vision problems affecting children worldwide....
... only contact lenses designed to address two ... eyes: presbyopia and eye dryness. , Only ... design, Balanced Progressive Technology, with a unique ... Technology. The result? Lenses that give you ...
... encountered complication in cataract surgery. Should a ... many surgeons advocate the use of flexible iris ... for maximum visibility during the procedure. These ... and can be easily inserted through four evenly ...
Medicine Products: